Systematic screening approach to identify new therapeutics for preeclampsia

确定先兆子痫新疗法的系统筛选方法

• 批准号: nhmrc : GNT1101871
• 负责人: Dr Natalie Hannan
• 金额: $ 72.75万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/systematic-screening-approach-therapeutics-preeclampsia/1346181
• 关键词: Systematic; screening; approach; identify; new

Preeclampsia is a pregnancy complication where factors are released from the placenta into the mum's bloodstream, causing widespread blood vessel and organ damage. Sadly, there is no treatment. Our laboratory has a set up a system to test whether drugs might be useful as a treatment for preeclampsia. We test whether the drugs decrease the release of these factors and protect blood vessels. In this grant, we propose testing three exciting drug treatments for preeclampsia.

先兆子痫是一种妊娠并发症，其中因子从胎盘释放到母亲的血液中，导致广泛的血管和器官损伤。可悲的是，没有治疗方法。我们的实验室已经建立了一个系统来测试药物是否可以用于治疗先兆子痫。我们测试药物是否减少这些因子的释放并保护血管。在这项资助中，我们提出测试三种令人兴奋的药物治疗先兆子痫。